Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

(NQ: )

N/A UNCHANGED
Last Price Updated: Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about

< Previous 1 2 3 4 5 6 7 8 9
...
37 38 Next >
Dendreon Announces Strong Commercial Start to 2015
From Business Wire News Releases
Earnings Forecast Recap for Alibaba, Apple, Zynga, Gilead Sciences, Dendreon, and Juniper
From PR Newswire
Technical Pulse on Biotech Stocks - Dendreon, Alkermes, Exact Sciences, Inovio Pharma, and Seattle Genetics
Editor Note: For more information about this release, please scroll to bottom. 
From PR Newswire
Dendreon Reaches Agreements on Terms of Financial Restructuring
From Business Wire News Releases
Technical Coverage on Biotech Stocks - Exelixis, Arena Pharma, Novavax, Dendreon, and Amicus Therapeutics
Editor Note: For more information about this release, please scroll to bottom. 
From PR Newswire
Biotech Equities Technical Momentum -- InterMune, Biogen Idec, Insmed, Dendreon, and Alexion Pharma
Editor Note: For more information about this release, please scroll to bottom 
From PR Newswire
Rodman & Renshaw 2014 Annual Global Investment Conference to be held in New York from September 8 to 10, 2014
From Business Wire News Releases
Dendreon Names W. Thomas Amick President and Chief Executive Officer
From Business Wire News Releases
Technical Data on Health Care Sector Equities -- Research on Achillion Pharma, Novavax, Dendreon, and Exelixis
Editor Note: For more information about this release, please scroll to bottom. 
From PR Newswire
Dendreon Announces Leadership Transition
From Business Wire News Releases
Technical Coverage on Health Care Sector Equities -- Research on Arena Pharma, Exelixis, Dendreon, and Seattle Genetics
Editor Note: For more information about this release, please scroll to bottom. 
From PR Newswire
Clinical Test Results, Improved Medical Care, and Rejection of Buyout Proposal by Medical Companies - Analyst Notes on AstraZeneca, LifePoint, Insmed, Dendreon and Idenix Pharmaceuticals
Editor Note: For more information about this release, please scroll to bottom 
From PR Newswire
Critical Alerts For JC Penney, Vipshop, Dendreon, Clovis Oncology, and Smith & Wesson Released By InvestorsObserver
From PR Newswire
Treatment with PROVENGE® (sipuleucel-T) Induces Antigen Spread Associated with Overall Survival Benefits In Advanced Prostate Cancer
From Business Wire News Releases
Dendreon Announces Presentation of PROVENGE® (sipuleucel-T) and DN24-02 Immuno-Oncology Data at the 2014 ASCO Annual Meeting
From Business Wire News Releases
Dendreon Announces First Quarter 2014 Results
From Business Wire News Releases
Pre-market Biotech Picks -- Research on Dendreon, Keryx Biopharma, Idera Pharma, and Vertex Pharma
Editor Note: For more information about this release, please scroll to bottom. 
From PR Newswire
Dendreon to Host Conference Call on May 8 to Announce First Quarter Financial Results
From Business Wire News Releases
Immune Responses Enhanced and Sustained When PROVENGE® (sipuleucel-T) is Given After Androgen Deprivation Therapy in Biochemically-Recurrent Prostate Cancer
From Business Wire News Releases
Pre-Market Pulse - Health Care Sector Stocks -- Research on Exelixis, StemCells, Dendreon, and Vivus
Editor Note: For more information about this release, please scroll to bottom. 
From PR Newswire
Price Movements, Clinical Trial Results, and Solid Financial Reports - Analyst Notes on Pfizer, Dendreon, DepoMed, Globus Medical, and Array
Editor Note: For more information about this release, please scroll to bottom. 
From PR Newswire
Critical Alerts For Dendreon, Qualcomm, Urban Outfitters, LinkedIn, and Proto Labs Released By InvestorsObserver
From PR Newswire
BlackBerry Limited (NASDAQ:BBRY) and Dendreon Corp. (NASDAQ:DNDN) Added to Equity Profile Report's NASDAQ Gainers Watch List.
Wilmington, DE -- (SBWIRE) -- 03/03/2014 -- Equity Profile Report expands its NASDAQ Gainers Weekly Watch List adding BlackBerry Limited (NASDAQ:BBRY) and Dendreon Corp. (NASDAQ:DNDN). 
From SBWire - Latest Press Releases
Dendreon Announces Plans to Make PROVENGE® Commercially Available in Europe
From Business Wire News Releases
Dendreon Announces Fourth Quarter and 2013 Year End Results
From Business Wire News Releases
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into DENDREON CORP. Regarding Possible Breaches of Fiduciary Duty
From PR Newswire
Dendreon Announces Webcast Presentation at Cowen and Company Health Care Conference
From Business Wire News Releases
Dendreon to Host Conference Call on March 3 to Announce Fourth Quarter and Full Year 2013 Financial Results
From Business Wire News Releases
Stocks on the Run - Laboratory Corp. of America Holdings (NYSE:LHI), Dendreon Corporation (NASDAQ:DNDN), Tenet Healthcare Corp (NYSE:THC), PDL BioPharma Inc. (NASDAQ:PDLI)
New York, NY -- (SBWIRE) -- 02/01/2014 -- To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”. 
From SBWire - Latest Press Releases
Notable Movers - Dendreon Corporation (NASDAQ:DNDN), Companhia Siderurgica Nacional (ADR) (NYSE:SID), Rapid Fire Marketing Inc (OTCMKTS:RFMK), PDL BioPharma Inc (NASDAQ:PDLI)
New York, NY -- (SBWIRE) -- 01/31/2014 -- CaddyStocks.com is keen to discover penny stocks with the potential to make short and long-term gains.We’ve been improving our skills as traders and analysts... 
From SBWire - Latest Press Releases
< Previous 1 2 3 4 5 6 7 8 9
...
37 38 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.